VEGFR2/CD309 Antikörper
Kurzübersicht für VEGFR2/CD309 Antikörper (ABIN2477091)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- Synthetic peptide: internal domain of human VEGF receptor 2, conjugated to Keyhole Limpet Hemocyanin (KLH).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
-
-
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." in: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
: "
-
Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." in: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- VEGF RECEPTOR 2
-
Hintergrund
- Synonyms: KDR
-
Gen-ID
- 3791
-
UniProt
- P35968
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-